I
About
ImmunoScape is a biotechnology company focused on developing novel immunotherapies and diagnostics for cancer. They leverage their proprietary platform to identify and target key immune pathways involved in cancer progression and treatment response. The company is actively pursuing clinical trials to validate their therapeutic candidates.
Tags
Performance
Company Timeline
No timeline data for this period
Score Breakdown
62Traction
38Team
70Visibility
0Profile
0Community
0Discussion (0)
Join the discussion
No comments yet. Be the first to share your thoughts!
Frequently Asked Questions
What does ImmunoScape do?
ImmunoScape is a biotechnology company focused on developing novel immunotherapies and diagnostics for cancer. They leverage their proprietary platform to identify and target key immune pathways involved in cancer progression and treatment response. The company is actively pursuing clinical trials to validate their therapeutic candidates.
How much funding has ImmunoScape raised?
ImmunoScape has raised a total of $50M in funding. The most recent round on record is Series B2.
Where is ImmunoScape headquartered?
ImmunoScape is headquartered in Singapore, Singapore.
When was ImmunoScape founded?
ImmunoScape was founded in 2017.
What industry does ImmunoScape operate in?
ImmunoScape operates in Biotechnology, Cancer, Immunotherapy, Diagnostics.